Multilineage Potential of Adult Human Mesenchymal Stem Cells
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Human mesenchymal stem cells are thought to be multipotent cells, which are present in adult marrow, that can replicate as undifferentiated cells and that have the potential to differentiate to lineages of mesenchymal tissues, including bone, cartilage, fat, tendon, muscle, and marrow stroma. Cells that have the characteristics of human mesenchymal stem cells were isolated from marrow aspirates of volunteer donors. These cells displayed a stable phenotype and remained as a monolayer in vitro. These adult stem cells could be induced to differentiate exclusively into the adipocytic, chondrocytic, or osteocytic lineages. Individual stem cells were identified that, when expanded to colonies, retained their multilineage potential.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, harvesting BM-MSCs is limited by the potential pain and morbidity associated with bone marrow aspiration, and only a small fraction (0.001–0.01%) of harvested bone marrow cells are MSCs [58,67].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [67]
Citations
Cites
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Caplan, A. I. (1991) · Journal of Orthopaedic Research · doi:10.1002/jor.1100090504 · Cited by 6,548
Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues
Prockop, D. J. (1997) · Science · doi:10.1126/science.276.5309.71 · Cited by 4,629
A Direct Measurement of the Radiation Sensitivity of Normal Mouse Bone Marrow Cells1
Till, J. E., & McCulloch, E. A. (2011) · Radiation Research · doi:10.1667/rrxx28.1 · Cited by 4,036
A Direct Measurement of the Radiation Sensitivity of Normal Mouse Bone Marrow Cells
Till, J. E., & McCulloch, E. A. (1961) · Radiation Research · doi:10.2307/3570892 · Cited by 3,708
In VitroChondrogenesis of Bone Marrow-Derived Mesenchymal Progenitor Cells
Johnstone, B., Hering, T. M., Caplan, A. I., Goldberg, V. M., & Yoo, J. U. (1998) · Experimental Cell Research · doi:10.1006/excr.1997.3858 · Cited by 2,382
Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage.
Wakitani, S., Goto, T., Pineda, S. J., Young, R. G., Mansour, J. M., Caplan, A. I., & Goldberg, V. M. (1994) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-199404000-00013 · Cited by 1,605
Bruder, S. P., Jaiswal, N., & Haynesworth, S. E. (1997) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(199702)64:2<278::aid-jcb11>3.0.co;2-f · Cited by 1,485
Derivation of pluripotent stem cells from cultured human primordial germ cells
Shamblott, M. J., Axelman, J., Wang, S., Bugg, E. M., Littlefield, J. W., Donovan, P. J., Blumenthal, P. D., Huggins, G. R., & Gearhart, J. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13726 · Cited by 1,420
Circulating Fibrocytes Define a New Leukocyte Subpopulation That Mediates Tissue Repair
Bucala, R., Spiegel, L. A., Chesney, J., Hogan, M., & Cerami, A. (1994) · Molecular Medicine · doi:10.1007/bf03403533 · Cited by 1,308
Research works printed but not linked: 4
- ; M. Owen and A. J. Friedenstein in Cell and Molecular Biology of Vertebrate Hard Tissues D. Evered and S. Harnett Eds. (Wiley Chichester UK 1988) pp. 42–60.
- Friedenstein A. J., Chailakhyan R. K., Gerasimov U. V., Cell Tissue Kinet. 20, 263 (1987);
- Bab I., Howlett C. R., Ashton B. A., Owen M. E., ibid. 187, 243 (1984).
- We thank D. Fink J. Andres R. Deans F. Barry S Bruder M. Thiede A. Moseley and J. Burns for discussion and review of the manuscript; M. Black and M. Earlington for cell isolation from marrow; and D. Sterchi D. Brown and J. Skwarek for histology. This work was supported by Osiris Therapeutics (www.osiristx.com) and in part by a research contract from the Defense Advanced Research Projects Agency.
Cited by
Items 1,601–1,647 of 1,647
Du, J., Zhou, L., Chen, X., Yan, S., Ke, M., Lu, X., Wang, Z., Yu, W., & Xiang, A. P. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.04.015 · Cited by 41
Carey, H. A., Hildreth, B. E., Geisler, J. A., Nickel, M. C., Cabrera, J., Ghosh, S., Jiang, Y., Yan, J., Lee, J., Makam, S., et al. (2018) · Bone Research · doi:10.1038/s41413-018-0011-1 · Cited by 40
“Bone forming OBs originate from multipotent mesenchymal stem cells (MSCs), which also give rise to multiple other cell types including adipocytes, chondrocytes, myocytes, and fibroblasts.(9) Within the OB lineage, runt-related transcription factor 2 (RUNX2) is perceived as the master regulator of OB differentiation an…”
BackgroundRengasamy, M., Singh, G., Fakharuzi, N. A., Siddikuzzaman, Balasubramanian, S., Swamynathan, P., Thej, C., Sasidharan, G., Gupta, P. K., Das, A. K., et al. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0595-1 · Cited by 39
“Among various types of stem cells, mesenchymal stromal cells (MSCs) are the preferred cell type due to their easy isolation, high expandability, multilineage differentiation potential, and paracrine activity [7].”
Kuruvilla, K. P., Nandhu, M. S., Paul, J., & Paulose, C. S. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.04.020 · Cited by 38
“These cells normally differentiate into bone, cartilage and adipose tissue [62], but can be induced to differentiate into cells with surface markers characteristic of neurons [63].”
BackgroundGenetic Engineering of Mesenchymal Stem Cells for Regenerative Medicine
Nowakowski, A., Walczak, P., Janowski, M., & Lukomska, B. (2015) · Stem Cells and Development · doi:10.1089/scd.2015.0062 · Cited by 38
“Thesimplicity of obtaining these cells from different organs and the subsequent ease of propagation in vitro [4], as well as the potential for autologous transplantation, make them a tempting possibility for clinical use.”
Yadav, P., Vats, R., Bano, A., & Bhardwaj, R. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118588 · Cited by 36
Macrophages as a Cell-Based Therapy for Liver Disease
Starkey Lewis, P. J., Moroni, F., & Forbes, S. J. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1688502 · Cited by 36
Ye, F., Li, J., Xu, P., Xie, Z., Zheng, G., Liu, W., Ye, G., Yu, W., Lin, J., Su, Z., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02735-0 · Cited by 35
“It has been reported that abnormal secretion of a variety of cytokines affects the immunoregulatory capacity of MSCs [10]; interleukin (IL)-8, also known as C-X-C motif chemokine ligand 8 (CXCL8), is one of the most essential immunomodulatory factors and was initially demonstrated to play important roles in the activa…”
RetractedSchmidtke-Schrezenmeier, G., Urban, M., Musyanovych, A., Mailänder, V., Rojewski, M., Fekete, N., Menard, C., Deak, E., Tarte, K., Rasche, V., et al. (2011) · Cytotherapy · doi:10.3109/14653249.2011.571246 · Cited by 34
BULUT, Ö., & GÜRSEL, İ. (2020) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-2002-79 · Cited by 34
“1 Mesenchymal stem/stromal cells (MSCs) Mesenchymal stem cells, also known as mesenchymal stromal cells (MSCs), are multipotent cells with selfrenewal capacity and the ability to differentiate into mesenchymal lineages such as osteogenic, chondrogenic and adipogenic (Pittenger et al., 1999).”
BackgroundVarious Three-Dimensional Culture Methods and Cell Types for Exosome Production
Lee, D.-H., Yun, D. W., Kim, Y. H., Im, G.-B., Hyun, J., Park, H. S., Bhang, S. H., & Choi, S. H. (2023) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-023-00551-y · Cited by 33
Santinoni, C. S., Neves, A. P. C., Almeida, B. F. M., Kajimoto, N. C., Pola, N. M., Caliente, E. A., Belem, E. L. G., Lelis, J. B., Fucini, S. E., Messora, M. R., et al. (2021) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.37076 · Cited by 32
Angiogenic activity of mesenchymal stem cells in multiple myeloma
Wang, X., Zhang, Z., & Yao, C. (2011) · Cancer Investigation · doi:10.3109/07357907.2010.496758 · Cited by 32
Horwitz, E. M., Andreef, M., & Frassoni, F. (2007) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2006.10.016 · Cited by 31
The role of mesenchymal stem cells in cancer and prospects for their use in cancer therapeutics
Tang, J., Chen, Y., Wang, C., Xia, Y., Yu, T., Tang, M., Meng, K., Yin, L., Yang, Y., Shen, L., et al. (2024) · MedComm · doi:10.1002/mco2.663 · Cited by 31
“55,56 Even with extensive research over the years, there is still no comprehensive understanding of how to classify bone marrow MSCs in vitro.”
BackgroundAyadilord, M., Nasseri, S., Emadian Razavi, F., Saharkhiz, M., Rostami, Z., & Naseri, M. (2021) · Cell Biochemistry and Function · doi:10.1002/cbf.3659 · Cited by 30
The role of bone marrow derived mesenchymal stem cells in sports injuries
Vris, A., Aresti, N., Khan, W. S., & Malik, A. A. (2016) · Stem Cells in Clinical Applications · doi:10.1007/978-3-319-40144-7_14 · Cited by 28
Zheng, H., Zou, W., Shen, J., Xu, L., Wang, S., Fu, Y.-X., & Fan, W. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0300 · Cited by 28
Noh, J.-E., Oh, S.-H., Park, I.-H., & Song, J. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.546659 · Cited by 28
“, 2012]; and they are present in abundance, found in bone marrow (Pittenger et al., 1999), adipose tissue (Zuk et al.”
BackgroundCHEN, Q., CHENG, P., YIN, T., HE, H., YANG, L., WEI, Y., & CHEN, X. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1015 · Cited by 27
“This differentiation plasticity makes MSCs the ultimate candidates for future utilization in cell therapy and tissue regeneration (16,17).”
New perspectives on arteriosclerosis treatment using nanoparticles and mesenchymal stem cells
Farokhi, S., Razavi, Z.-S., Mavaei, M., Shadab, A., Afkhami, H., & Sardarabadi, H. (2024) · Discover Applied Sciences · doi:10.1007/s42452-024-06113-8 · Cited by 27
Vargas-Rodríguez, P., Cuenca-Martagón, A., Castillo-González, J., Serrano-Martínez, I., Luque, R. M., Delgado, M., & González-Rey, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814117 · Cited by 25
“Depending on the source and intended use of the (allogeneic versus autologous) MSCs, the need of an extensive culturing process can also increase the senescence of MSCs, ultimately affecting the proliferative rates and their therapeutic efficacy [205,206].”
Wang, Y., Lee, J.-H., Shirahama, H., Seo, J., Glenn, J. S., & Cho, N.-J. (2016) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00487 · Cited by 21
Yarahmadi, A., Dorri Giv, M., Hosseininejad, R., Rezaie, A., Mohammadi, N., Afkhami, H., & Farokhi, A. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1472679 · Cited by 21
Olufsen, M., & Arukwe, A. (2011) · Aquatic Toxicology · doi:10.1016/j.aquatox.2011.09.005 · Cited by 20
Baron, M., Drohat, P., Crawford, B., Hornicek, F. J., Best, T. M., & Kouroupis, D. (2023) · Bioengineering · doi:10.3390/bioengineering10101187 · Cited by 19
“%) of harvested bone marrow cells are MSCs [58,67].”
BackgroundKolliopoulos, V., Tiffany, A., Polanek, M., & Harley, B. A. C. (2023) · doi:10.1101/2023.11.12.566781 · Cited by 17
Shah, K., Shah, N., Ghassemi, F., Ly, C., George, T., Lutz, C., & Sumer, H. (2022) · Stem Cells International · doi:10.1155/2022/9589600 · Cited by 17
Zhao, N., Gao, Y.-F., Bao, L., Lei, J., An, H.-X., Pu, F.-X., Cheng, R.-P., Chen, J., Ni, H., Sui, B.-D., et al. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02467-7 · Cited by 16
“Mesenchymal stem cells (MSCs) are a subset of multipotent stem cells with the capacity of immunomodulation/anti-inflammation through secreting cytokines, which makes them promising candidates for stem cellbased therapy [11, 12].”
BackgroundKayaba, A., Itoh-Nakadai, A., Niibe, K., Shirota, M., Funayama, R., Sugahara-Tobinai, A., Wong, Y. L., Inui, M., Nakayama, K., & Takai, T. (2018) · International Immunology · doi:10.1093/intimm/dxy018 · Cited by 16
Hur, C.-I., Ahn, H.-W., Seon, J.-K., Song, E.-K., & Kim, G.-E. (2019) · International Journal of Stem Cells · doi:10.15283/ijsc18022 · Cited by 15
“into variable cell types, including osteoblasts, chondrocytes, adipocyte and tenocytes (20-22), and are being”
BackgroundBiology and Therapeutic Properties of Mesenchymal Stem Cells in Leukemia
Wu, C.-H., Weng, T.-F., Li, J.-P., & Wu, K.-H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052527 · Cited by 13
“Their interaction prevents HSC differentiation, protects against apoptosis, and promotes self -renewal [2,25].”
BackgroundPlatelet-rich plasma treatment for talar cartilage repair: a systematic review and meta-analysis
Peng, J., Wang, Q., Xu, Y., & He, H. (2023) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-023-06466-y · Cited by 13
Yeh, S.-P., Chang, J.-G., Lin, C.-L., Lo, W.-J., Lee, C.-C., Lin, C.-Y., & Chiu, C.-F. (2005) · Leukemia · doi:10.1038/sj.leu.2403795 · Cited by 12
Yoon, J.-Y., Kim, T.-S., Ahn, J.-H., Yoon, J.-U., Kim, H.-J., & Kim, E.-J. (2019) · Journal of Dental Anesthesia and Pain Medicine · doi:10.17245/jdapm.2019.19.2.91 · Cited by 12
“They originate from mesenchymal stem cells and can differentiate into mature osteoblasts [4].”
BackgroundAljuhani, A., Albalawi, O., Albalawi, R., Alsalama, R., Alatawi, S., Altemani, R., Abdel‐Maksoud, M. S., & Elsherbiny, N. (2023) · Cell Biology International · doi:10.1002/cbin.12014 · Cited by 12
“MSCs are easily accessible cells that can be isolated from many tissues such as bone marrow, umbilical cord, | 1057 adipose tissues, placenta, and dental pulp (Pittenger et al., 1999) (Ullah et al., 2015).”
BackgroundGiannotti, S., Trombi, L., Bottai, V., Ghilardi, M., D'Alessandro, D., Danti, S., Dell'Osso, G., Guido, G., & Petrini, M. (2013) · PLoS ONE · doi:10.1371/annotation/e4403abb-b80e-43c5-be74-1bdb2c899d1c · Cited by 12
Controversies regarding transplantation of mesenchymal stem cells
Velikova, T., Dekova, T., & Miteva, D. G. (2024) · World Journal of Transplantation · doi:10.5500/wjt.v14.i2.90554 · Cited by 12
Choi, J. E., Hur, W., Kim, J.-H., Li, T. Z., Lee, E. B., Lee, S. W., Kang, W., Shin, E.-C., Wakita, T., & Yoon, S. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091958 · Cited by 12
Nagai, H., Miwa, A., Yoneda, K., Fujisawa, K., & Takami, T. (2023) · Bioengineering · doi:10.3390/bioengineering10010102 · Cited by 9
He, L., Xu, J., Huang, P., Bai, Y., Chen, H., Xu, X., Hu, Y., Liu, J., & Zhang, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137235 · Cited by 8
“…after three passages of culture, expressing the MSC markers CD44, CD90, CD105, and CD73, but not the hematopoietic markers CD34 and CD45 [9,27], and could differentiate into osteoblasts, chondrocytes, and adipocytes upon appropriate osteogenic, chondrogenic, and adipogenic induction…”
BackgroundGebraad, A., Ohlsbom, R., Miettinen, J. J., Emeh, P., Pakarinen, T.-K., Manninen, M., Eskelinen, A., Kuismanen, K., Slipicevic, A., Lehmann, F., et al. (2022) · Cells · doi:10.3390/cells11091574 · Cited by 8
“Mesenchymal stem/stromal cells (MSCs) are self-renewing and multipotent progenitors that can differentiate into a variety of cell types, such as adipocytes, osteoblasts and pericytes, which constitute the main cellular compartment of bone marrow stroma [2,3].”
BackgroundBone Marrow Stromal Cells Control the Growth of Hepatic Stellate Cells in vitro
Shi, L., Li, G., Wang, J., Sun, B., Yang, L., Wang, G., Wang, D., Mu, L., Chen, H., Jin, L., et al. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-008-0227-9 · Cited by 7
“Bone marrow stromal cells (BMSCs) are multipotent stem cells capable of self-renewal and with multilineagedifferentiating capacity [9–11].”
BackgroundMesenchymal Stem Cells for Cutaneous Wound Healing
Camões, S. P., Santos, J. M., Carvalho, F., & Miranda, J. P. (2020) · Learning Materials in Biosciences · doi:10.1007/978-3-030-43939-2_13 · Cited by 6
The role of mesenchymal stem cells in oncology and regenerative medicine
Maliha, K., Syeda Ezze Rukhshan, A., & Amanda L, O. (2017) · Future Oncology · doi:10.2217/fon-2016-0264 · Cited by 5
Pan, X., Gao, T., & Wang, B. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01520-9 · Cited by 2
“BM-MSCs were the first identified and the most commonly studied MSCs in pre-clinical and clinical studies [311].”
Warrington (2001) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200101)44:1 · Cited by 2
Metadata
- Authors
- Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R.
- Affiliations
- Osiris Therapeutics (United States) (US)
- Johns Hopkins University (US)
- Corresponding author
- Pittenger, Mark F.
- ORCID
- Pittenger, Mark F.
- Venue
- Science
- Published
- 1999-04-02
- Volume
- 284
- Issue
- 5411
- Pages
- 143-147
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2159999899
- Cited by
- 21,052
- References
- 37
- Citations by year
- 2026: 265 · 2025: 373 · 2024: 497 · 2023: 541 · 2022: 604 · 2021: 778 · 2020: 856 · 2019: 766 · 2018: 884 · 2017: 962 · 2016: 1083 · 2015: 1145 · 2014: 1255 · 2013: 1344 · 2012: 1384
- FWCI
- 138.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Keywords
- mesenchymal stem cells, multilineage differentiation, multipotency, bone marrow, adipogenesis, chondrogenic differentiation, osteogenic differentiation, stem cell isolation, colony expansion, stem cell phenotype
- MeSH terms
- Adult, Bone Marrow Cells, Cell Differentiation, Cell Division, Cell Separation, Cells, Cultured, Fibroblasts, Flow Cytometry, Humans, Mesoderm, Middle Aged, Osteocytes, Phenotype, Stem Cells, Apoptosis, Adipocytes, Cell Lineage, Chondrocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.